Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma.
Frontiers in molecular biosciences
Wang C, Guo J, Jiang R, Wang C, Pan C, Nie Z, Jiang X.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2022
Cancer Research
Immunology
No items found.
Key Finding
Receiver operating curve (ROC) analysis revealed the significant diagnostic ability of AP000695.2 (AUC = 0.838). The findings confirmed that AP000695.2 was involved in the progression of lung adenocarcinoma, providing a novel prognostic indicator and promising diagnostic biomarker in the future.
Countstar Connection
Countstar (model not specified) measured cell numbers during growth assessment in the study's cell samples during migration assessment in the 2022 Frontiers in molecular biosciences study.
